ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1548

Q Fever as a Mimicker of Rheumatologic Conditions: A Case Series from Two Tertiary Care Academic Centers in Southern California

Manushi Aggarwal and Marven Cabling, Loma Linda University Health, Redlands, CA

Meeting: ACR Convergence 2021

Keywords: autoimmune diseases, Autoinflammatory diseases, Infection, Still's disease, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Infection-related Rheumatic Disease Poster (1530–1564)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Q fever, an endemic disease in Southern California, is a zoonosis caused by Coxiella burnetii. The infection can present with multiple non-specific acute and chronic manifestations including fever, headache, fatigue, endocarditis, and hepatitis. Q fever is also associated with the presence of elevated inflammatory markers and autoimmune antibodies. This combination of the clinical picture and laboratory features may be misinterpreted for various rheumatologic conditions.

Methods: We evaluated records of patients who were newly diagnosed with Q-fever during an inpatient stay at 2 academic medical centers from 2013 to 2021. Data was collected for all Q fever cases in whom rheumatology was consulted, including demographics, symptoms on admission, comorbidities, labs, imaging, tissue sample obtained, and medical specialties consulted. Inpatient rheumatology consultation reports were reviewed. The reason for the consult, differential diagnosis, the time it took from admission to rheumatology consult, and rheumatology consult to Q fever diagnosis were analyzed. 

Results: From 2013-2021, 23 patients were diagnosed with Q fever during an inpatient stay. Eight patients (34.7%) received rheumatology consultation prior to their Q fever diagnosis. Majority of the patients (62.5%) had symptom onset during the first quarter of the year, 75% of patients had exposure to cattle, sheep, goat, or rats, 37.5% had domestic pet exposure, and 1 patient did not report any known animal exposure. Almost all (87.5%) patients had fever and flu-like symptoms, with 63% having GI symptoms. All patients had extensive infectious workup done. All patients had elevated inflammatory markers, and 63% with abnormal liver enzymes. One patient had a low titer antinuclear antibody and another one had a positive rheumatoid factor. Two patients underwent liver biopsy showing ring granulomas and granulomatous hepatitis, findings characteristic but not pathognomonic of Q fever.   

Fever of unknown origin (FUO) was the most common (75%) reason for consultation while one patient each was referred for evaluation for giant cell arteritis (GCA) and sarcoidosis. In 50% of cases, the rheumatology service thought a rheumatologic disease is less likely and thus recommended additional studies for infectious or oncologic etiology. Rheumatologic differentials included adult-onset Still’s disease, Bechet’s disease, sarcoidosis, and systemic vasculitis including GCA. An auto-inflammatory gene panel was done in 2 patients and temporal artery biopsy was done in 1 patient with results all negative. On average, Q fever was diagnosed approximately 10.6 days after admission and 5.8 days after rheumatology consultation.  

Conclusion: The non-specific presentation of Q fever, accompanied by elevated inflammatory markers, and autoimmune antibodies can mimic various rheumatologic conditions including vasculitis, Still’s disease, and sarcoidosis. Our case series demonstrates that Q-fever should be considered as a differential diagnosis especially for patients with FUO and residing in endemic regions.  

Table 1. Patient demographics and presenting symptoms of patients diagnosed with Q fever patients who received Rheumatology inpatient consultation (n=8)

Table 2. Work-up done prior to rheumatology consult, specialties consulted, and abnormal results

Table 3. Details on rheumatology consultation, differentials, and workup


Disclosures: M. Aggarwal, None; M. Cabling, None.

To cite this abstract in AMA style:

Aggarwal M, Cabling M. Q Fever as a Mimicker of Rheumatologic Conditions: A Case Series from Two Tertiary Care Academic Centers in Southern California [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/q-fever-as-a-mimicker-of-rheumatologic-conditions-a-case-series-from-two-tertiary-care-academic-centers-in-southern-california/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/q-fever-as-a-mimicker-of-rheumatologic-conditions-a-case-series-from-two-tertiary-care-academic-centers-in-southern-california/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology